EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Determination of the Level of von Willebrand Factor, ADAMTS13, and Ratio of ADAMTS13:von Willebrand Factor in Sickle Cell Disease Patients

Akaba Kingsley Onorhide, Akpan Samuel Idongesit, Osho Patrick Olanrewaju

Annals of African Medicine · 2025

DOI: 10.4103/aam.aam_25_22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of African Medicine, 2025. Verfasst von Akaba Kingsley Onorhide und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology and Blood Transfusion, University of Calabar Teaching Hospital, Calabar, Cross River State, Nigeria. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, ADAMTS13 Protein, von Willebrand Factor. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sickle cell anemia (SCA) is a hypercoagulable state characterized by a significant alteration in hemostatic parameters which may predispose an increased risk of vaso-occlusive crisis (VOC). Sickle cell disease (SCD) is the most common genetic disorder in sub-Saharan Africa. Nigeria bears a high disease burden with an estimated prevalence of 1%–3% of its population being affected by the disease. The study seeks to determine the role of von Willebrand factor (VWF), ADAMTS13, and the ratio of ADAMTS13:VWF antigen in the pathogenesis of VOC.

Objective

The objective of this study is to evaluate the level of VWF, ADAMTS13, and their ratio in SCD subjects in Calabar and to determine their role in the pathogenesis of VOC. Methodology: This is a comparative study carried out at the University of Calabar Teaching Hospital (UCTH), Calabar. Sixty SCA patients were evaluated in VOC and steady states as well as five parented healthy controls. VWF: Ag and ADAMTS13:Ag were evaluated using Assaypro enzyme-linked immunosorbent assay kits with Lot nos. 01751728 and 04222167R, respectively. Data were analyzed by IBM SPSS Chicago software version 21. The study was approved by the UCTH Institution Ethical Review Board.

Results

The mean ages of the SCA subjects and controls were 23.5 ± 7.2 years and 26.5 ± 5.6 years, respectively ( P = 0.706). There were 23 (38.3%) males in the SCA group and 21 (42.0%) females in the controls. There was no significant difference in their sex distribution ( P = 0.063). The mean (standard deviation [SD]) of VWF in VOC, steady state, and controls were 2.52 ± 0.34, 1.34 ± 0.23, and 1.41 ± 0.23 IU/mL, respectively. The differences in mean were significantly higher in VOC state ( P = 0.003). The mean ± SD of ADAMTS13 in VOC, steady state, and controls were 0.61 ± 0.10, 0.44 ± 0.06, and 0.62 ± 0.10 µg/L, respectively. ADAMTS13 levels did not differ significantly across the groups ( P = 0.270). Similarly, there was no significant difference between ADAMTS13:VWF ratios across the groups ( P = 0.318).

Conclusion

VWF level is elevated in VOC state and thus may be implicated in the pathogenesis of VOC. ADAMTS13 and the ratio of ADAMTS13:VWF are not significantly affected in VOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellADAMTS13 Proteinvon Willebrand FactorHumansFemaleMaleAdultNigeriaAdolescentYoung AdultCase-Control StudiesEnzyme-Linked Immunosorbent AssayBiomarkers

Stichwörter der Autor:innen

ADAMTS13facteur von Willebrandmaladie de la drépanocytosesickle cell diseasevon Willebrand factor

Substanzen

ADAMTS13 Proteinvon Willebrand FactorADAMTS13 protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Haematology and Blood Transfusion, University of Calabar Teaching Hospital, Calabar, Cross River State, Nigeria.
  • Department of Haematology and Blood Transfusion, University of Uyo, Calabar, Cross River State, Nigeria.
  • Department of Haematology, Ondo State University of Medical Sciences, Ondo City, Ondo State, Nigeria.

Zitieren

APA

Onorhide, A. K., Idongesit, A. S., & Olanrewaju, O. P. (2025). Determination of the Level of von Willebrand Factor, ADAMTS13, and Ratio of ADAMTS13:von Willebrand Factor in Sickle Cell Disease Patients. Annals of African Medicine. https://doi.org/10.4103/aam.aam_25_22

Vancouver

Onorhide AK, Idongesit AS, Olanrewaju OP. Determination of the Level of von Willebrand Factor, ADAMTS13, and Ratio of ADAMTS13:von Willebrand Factor in Sickle Cell Disease Patients. Annals of African Medicine. 2025. doi:10.4103/aam.aam_25_22

BibTeX
@article{Onorhide2025,
  author = {Onorhide, Akaba Kingsley and Idongesit, Akpan Samuel and Olanrewaju, Osho Patrick},
  title = {Determination of the Level of von Willebrand Factor, ADAMTS13, and Ratio of ADAMTS13:von Willebrand Factor in Sickle Cell Disease Patients},
  journal = {Annals of African Medicine},
  year = {2025},
  doi = {10.4103/aam.aam_25_22}
}
Kostenlos starten →